Live Fluorescent RNA‐Based Detection of Pluripotency Gene Expression in Embryonic and Induced Pluripotent Stem Cells of Different Species

The generation of induced pluripotent stem (iPS) cells has successfully been achieved in many species. However, the identification of truly reprogrammed iPS cells still remains laborious and the detection of pluripotency markers requires fixation of cells in most cases. Here, we report an approach with nanoparticles carrying Cy3‐labeled sense oligonucleotide reporter strands coupled to gold‐particles. These molecules are directly added to cultured cells without any manipulation and gene expression is evaluated microscopically after overnight incubation. To simultaneously detect gene expression in different species, probe sequences were chosen according to interspecies homology. With a common target‐specific probe we could successfully demonstrate expression of the GAPDH house‐keeping gene in somatic cells and expression of the pluripotency markers NANOG and GDF3 in embryonic stem cells and iPS cells of murine, human, and porcine origin. The population of target gene positive cells could be purified by fluorescence‐activated cell sorting. After lentiviral transduction of murine tail‐tip fibroblasts Nanog‐specific probes identified truly reprogrammed murine iPS cells in situ during development based on their Cy3‐fluorescence. The intensity of Nanog‐specific fluorescence correlated positively with an increased capacity of individual clones to differentiate into cells of all three germ layers. Our approach offers a universal tool to detect intracellular gene expression directly in live cells of any desired origin without the need for manipulation, thus allowing conservation of the genetic background of the target cell. Furthermore, it represents an easy, scalable method for efficient screening of pluripotency which is highly desirable during high‐throughput cell reprogramming and after genomic editing of pluripotent stem cells. Stem Cells 2015;33:392–402

[1]  M. Hendrix,et al.  Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal. , 2014, Seminars in oncology.

[2]  Bahram Valamehr,et al.  Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells , 2014, Stem cell reports.

[3]  D. Greaves,et al.  The PYRIN domain-only protein POP3 inhibits AIM2-like receptor inflammasomes and regulates responses to DNA virus infections , 2014, Nature Immunology.

[4]  J. I. Izpisúa Belmonte,et al.  A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells* , 2013, The Journal of Biological Chemistry.

[5]  Y. Yoon,et al.  Abstract 14396: Purification of Cardiomyocytes From Differentiating Pluripotent Stem Cells Using Molecular Beacons Targeting Cardiomyocyte-specific mRNA , 2013 .

[6]  Y. Yoon,et al.  Purification of Cardiomyocytes from Differentiating Pluripotent Stem Cells using Molecular Beacons Targeting Cardiomyocyte- Specific mRNA , 2014 .

[7]  M. Rao iPSC crowdsourcing: a model for obtaining large panels of stem cell lines for screening. , 2013, Cell stem cell.

[8]  R. Martinez,et al.  A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells , 2013, Molecular and Cellular Neuroscience.

[9]  L. Conti,et al.  Neural stem cells as tools for drug discovery: novel platforms and approaches , 2013, Expert opinion on drug discovery.

[10]  Jennifer Nichols,et al.  A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages , 2013, Nature Cell Biology.

[11]  J. C. Belmonte,et al.  Characterization of pluripotent stem cells , 2013, Nature Protocols.

[12]  L. Studer,et al.  Adapting human pluripotent stem cells to high-throughput and high-content screening , 2012, Nature Protocols.

[13]  M. Longaker,et al.  Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell–Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation , 2012, Circulation research.

[14]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[15]  MasashiKawamura,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012 .

[16]  T. Shinozawa,et al.  Determination of Appropriate Stage of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes for Drug Screening and Pharmacological Evaluation In Vitro , 2012, Journal of biomolecular screening.

[17]  Robert Zweigerdt,et al.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.

[18]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[19]  M. Rao,et al.  Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells , 2012, Stem Cell Reviews and Reports.

[20]  M. Baker Reprogramming: faithful reporters , 2012, Nature Methods.

[21]  S. Gronthos,et al.  Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. , 2011, Journal of periodontal research.

[22]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[23]  Young‐Tae Chang,et al.  Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1 , 2011, Nature Protocols.

[24]  Linzhao Cheng,et al.  Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. , 2011, Blood.

[25]  S. Suhr,et al.  Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. , 2011, Stem cells and development.

[26]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[27]  Lei Xiao,et al.  Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors , 2011, Cell Research.

[28]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, The New England journal of medicine.

[29]  Lei Yang,et al.  Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.

[30]  G. Daley,et al.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.

[31]  D. Roberts,et al.  Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages , 2009, Nature.

[32]  C. Lim,et al.  Regulated Fluctuations in Nanog Expression Mediate Cell Fate Decisions in Embryonic Stem Cells , 2009, PLoS biology.

[33]  D. Pei,et al.  Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig* , 2009, The Journal of Biological Chemistry.

[34]  K. Hochedlinger,et al.  Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette , 2009, Stem cells.

[35]  Hui Li,et al.  Generation of induced pluripotent stem cell lines from adult rat cells. , 2009, Cell stem cell.

[36]  Meng Liu,et al.  Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. , 2008, Cell stem cell.

[37]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[38]  D. Clapham,et al.  In Brief , 2006, Nature Reviews Drug Discovery.

[39]  Yunfu Sun,et al.  Multipotent Embryonic Isl1 + Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification , 2006, Cell.

[40]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[41]  Ariel J. Levine,et al.  GDF3 at the Crossroads of TGF-beta Signaling , 2006, Cell cycle.

[42]  Karl-Ludwig Laugwitz,et al.  Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages , 2005, Nature.

[43]  A. Clark,et al.  Human STELLAR, NANOG, and GDF3 Genes Are Expressed in Pluripotent Cells and Map to Chromosome 12p13, a Hotspot for Teratocarcinoma , 2004, Stem cells.

[44]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[45]  D. Greaves,et al.  The PYRIN domain – only protein POP 3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses , 2014 .

[46]  A. Mehta,et al.  Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes. , 2014, Cardiovascular research.

[47]  Yalei Wu,et al.  TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells. , 2013, Methods in molecular biology.